"Altasciences est une entreprise de recherche contractuelle reconnue à l’international et spécialisée dans les essais cliniques de bioéquivalence et de Phase I/Ila. Les bureaux d'Altasciences au 1100 Beaumont s'occupent des rencontres médicales des participants et de la prise de rendez-vous. Du personnel est toujours sur place pour répondre à toutes questions sur les études, notre entreprise et la recherche clinique."

During the past decade, Altasciences conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altasciences" #1 sponsor was "Antios Therapeutics, Inc" with 3 trials, followed by "Galapagos NV" with 2 trials sponsored, "Grünenthal GmbH" with 1 trials sponsored, "Inversago Pharma Inc." with 1 trials sponsored and "Mutual Pharmaceutical Company, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altasciences" #1 collaborator was "Empiristat, Inc." with 1 trials as a collaborator and "ViiV Healthcare" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Altasciences" are "Healthy" (3 trials), "Drug Drug Interaction" (1 trials), "Drug Interaction" (1 trials), "HIV-1-infection" (1 trials) and "Healthy Volunteer" (1 trials). Many other conditions were trialed in "Altasciences" in a lesser frequency.

Most popular intervention types in "Altasciences" are "Drug" (10 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATI-2173" (2 trials), "Midazolam" (2 trials), "ATI-2173 50 mg" (1 trials), "ATI-2173 Placebo" (1 trials) and "Clarithromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Altasciences" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Altasciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Altasciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Altasciences, 9 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".